Related Experiment Video
Updated: Aug 7, 2026

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
Published on: June 16, 2020
Progressive systemic sclerosis (PSS) and malignancy, pulmonary and non-pulmonary
This study investigates the link between progressive systemic sclerosis (PSS) and cancer, reviewing literature and case reports. Findings suggest a potential association between PSS and malignancy, particularly in the lungs.
Area of Science:
- Rheumatology
- Oncology
- Immunology
Background:
- Progressive systemic sclerosis (PSS) shares features with dermatomyositis-polymyositis, a condition known to associate with malignancy.
- Traditionally, the association between PSS and malignancy has been considered coincidental.
More Related Videos
09:08Isolating Human Peripheral Blood Mononuclear Cells and CD4+ T cells from Sézary Syndrome Patients for Transcriptomic Profiling
Published on: October 14, 2021
10:21Primary Sjogren's Syndrome Associated with Lung Adenocarcinoma: Probing the Potential Common Pathogenic Mechanisms and Experimental Verification
Published on: September 20, 2024
Related Concept Videos
Abnormal Proliferation
Other Pulmonary Disorders
Disorders of the Female Reproductive System
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Multiple Sclerosis l: Introduction